TY - JOUR
T1 - Next-generation contact lenses
T2 - Towards bioresponsive drug delivery and smart technologies in ocular therapeutics
AU - Chaudhari, Pinal
AU - Ghate, Vivek M.
AU - Lewis, Shaila A.
N1 - Funding Information:
The authors are grateful to the Department of Biotechnology (DBT), Government of India for providing Junior Research Fellowship to Chaudhari P., and Manipal College of Pharmaceutical Sciences (MCOPS) and Manipal Academy of Higher Education for their support in carrying out the literature search and access to databases.
Funding Information:
This work was supported by the Department of Biotechnology (DBT), Government of India [Grant number: BT/PR26970/NNT/28/1509/2017 ] provided to the corresponding author, Lewis SA, and the Junior Research Fellowship to the first author, Chaudhari P.
Publisher Copyright:
© 2021 Elsevier B.V.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/4
Y1 - 2021/4
N2 - In contrast to the conventional ocular formulations, contact lenses are well known for their diverse applications ranging from bio-sensing, prevention of myopia, cosmetics, and drug delivery. With a tremendous change in the lifestyle, contact lenses for therapeutic purposes have increased several fold. Contact lenses as medicated lenses suffer from several disadvantages, and to overcome the same numerous approaches have been explored. Researches worldwide have come a long way from cyclodextrin-based and vitamin E-based modified contact lenses to bioinspired approaches to enhance the effectiveness of the drug-eluting contact lenses. The bioinspired approach exploits bioinspired polymeric systems to enhance biocompatibility, specific molecule recognition technique by molecular imprinting, or stimuli-responsive system to improve the biocompatibility, drug loading, and drug delivery efficacy of the drug-eluting contact lenses. Moreover, recent innovations in ocular therapeutics such as nanowafers and microneedle contact lenses, and ocular patches have gained tremendous attention in ocular therapeutics. Another potential application of the contact lenses are smart lenses applied in the biosensing and diagnosis of various ocular disorders. The review summarizes and discusses the widespread therapeutic applications of next-generation contact lenses and various fabrication approaches, including its clinical implications, efforts taken by researchers in exploring the novel materials and diverse forms of the lenses, mechanisms of drug release, clinical trials, and their toxicity and safety concerns.
AB - In contrast to the conventional ocular formulations, contact lenses are well known for their diverse applications ranging from bio-sensing, prevention of myopia, cosmetics, and drug delivery. With a tremendous change in the lifestyle, contact lenses for therapeutic purposes have increased several fold. Contact lenses as medicated lenses suffer from several disadvantages, and to overcome the same numerous approaches have been explored. Researches worldwide have come a long way from cyclodextrin-based and vitamin E-based modified contact lenses to bioinspired approaches to enhance the effectiveness of the drug-eluting contact lenses. The bioinspired approach exploits bioinspired polymeric systems to enhance biocompatibility, specific molecule recognition technique by molecular imprinting, or stimuli-responsive system to improve the biocompatibility, drug loading, and drug delivery efficacy of the drug-eluting contact lenses. Moreover, recent innovations in ocular therapeutics such as nanowafers and microneedle contact lenses, and ocular patches have gained tremendous attention in ocular therapeutics. Another potential application of the contact lenses are smart lenses applied in the biosensing and diagnosis of various ocular disorders. The review summarizes and discusses the widespread therapeutic applications of next-generation contact lenses and various fabrication approaches, including its clinical implications, efforts taken by researchers in exploring the novel materials and diverse forms of the lenses, mechanisms of drug release, clinical trials, and their toxicity and safety concerns.
UR - http://www.scopus.com/inward/record.url?scp=85101853636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101853636&partnerID=8YFLogxK
U2 - 10.1016/j.ejpb.2021.02.007
DO - 10.1016/j.ejpb.2021.02.007
M3 - Article
C2 - 33607239
AN - SCOPUS:85101853636
SN - 0939-6411
VL - 161
SP - 80
EP - 99
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
ER -